Gilead Sciences, Inc. (GILD)
140.23
+0.86
(+0.62%)
USD |
NASDAQ |
Apr 01, 16:00
140.23
0.00 (0.00%)
After-Hours: 16:08
Gilead Sciences Research and Development Expense (TTM) : 5.688B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.281B |
| Johnson & Johnson | 14.72B |
| Eli Lilly & Co. | 13.34B |
| Arcellx, Inc. | 157.61M |
| Moderna, Inc. | 2.917B |